153 related articles for article (PubMed ID: 29226856)
21. Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition.
Dunand C; Hoffmann P; Sapin V; Blanchon L; Salomon A; Sergent F; Benharouga M; Sabra S; Guibourdenche J; Lye SJ; Feige JJ; Alfaidy N
Biol Reprod; 2014 Sep; 91(3):73. PubMed ID: 25122063
[TBL] [Abstract][Full Text] [Related]
22. Prokineticin receptor variants (PKR1-I379V and PKR2-V331M) are protective genotypes in human early pregnancy.
Su MT; Lin SH; Chen YC; Wu LW; Kuo PL
Reproduction; 2013 Jul; 146(1):63-73. PubMed ID: 23687280
[TBL] [Abstract][Full Text] [Related]
23. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
Keramidas M; Faudot C; Cibiel A; Feige JJ; Thomas M
J Endocrinol; 2008 Mar; 196(3):473-82. PubMed ID: 18310443
[TBL] [Abstract][Full Text] [Related]
24. Prokineticins in central and peripheral control of human reproduction.
Traboulsi W; Brouillet S; Sergent F; Boufettal H; Samouh N; Aboussaouira T; Hoffmann P; Feige JJ; Benharouga M; Alfaidy N
Horm Mol Biol Clin Investig; 2015 Nov; 24(2):73-81. PubMed ID: 26574895
[TBL] [Abstract][Full Text] [Related]
25. Prokineticin Ligands and Receptors Are Expressed in the Human Fetal Ovary and Regulate Germ Cell Expression of COX2.
Eddie SL; Childs AJ; Kinnell HL; Brown P; Jabbour HN; Anderson RA
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1197-205. PubMed ID: 26192875
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of prokineticin 1 and its receptors in bovine ovaries during the estrous cycle: involvement in corpus luteum regression and follicular atresia.
Kisliouk T; Friedman A; Klipper E; Zhou QY; Schams D; Alfaidy N; Meidan R
Biol Reprod; 2007 May; 76(5):749-58. PubMed ID: 17229935
[TBL] [Abstract][Full Text] [Related]
27. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
[TBL] [Abstract][Full Text] [Related]
28. Prokineticins and their G protein-coupled receptors in health and disease.
Zhao Y; Wu J; Wang X; Jia H; Chen DN; Li JD
Prog Mol Biol Transl Sci; 2019; 161():149-179. PubMed ID: 30711026
[TBL] [Abstract][Full Text] [Related]
29. Sustained Endocrine Gland-Derived Vascular Endothelial Growth Factor Levels Beyond the First Trimester of Pregnancy Display Phenotypic and Functional Changes Associated With the Pathogenesis of Pregnancy-Induced Hypertension.
Sergent F; Hoffmann P; Brouillet S; Garnier V; Salomon A; Murthi P; Benharouga M; Feige JJ; Alfaidy N
Hypertension; 2016 Jul; 68(1):148-56. PubMed ID: 27141059
[TBL] [Abstract][Full Text] [Related]
30. Unique expression and regulatory mechanisms of EG-VEGF/prokineticin-1 and its receptors in the corpus luteum.
Kisliouk T; Podlovni H; Meidan R
Ann Anat; 2005 Nov; 187(5-6):529-37. PubMed ID: 16320832
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic islet and stellate cells are the main sources of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 in pancreatic cancer.
Jiang X; Abiatari I; Kong B; Erkan M; De Oliveira T; Giese NA; Michalski CW; Friess H; Kleeff J
Pancreatology; 2009; 9(1-2):165-72. PubMed ID: 19077468
[TBL] [Abstract][Full Text] [Related]
32. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
Hoffmann P; Feige JJ; Alfaidy N
Placenta; 2007 Oct; 28(10):1049-58. PubMed ID: 17531315
[TBL] [Abstract][Full Text] [Related]
33. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.
Chung JY; Song Y; Wang Y; Magness RR; Zheng J
J Clin Endocrinol Metab; 2004 May; 89(5):2484-90. PubMed ID: 15126581
[TBL] [Abstract][Full Text] [Related]
35. Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma.
Ngan ES; Lee KY; Yeung WS; Ngan HY; Ng EH; Ho PC
Endocrinology; 2006 Jan; 147(1):88-95. PubMed ID: 16210375
[TBL] [Abstract][Full Text] [Related]
36. EG-VEGF: a key endocrine factor in placental development.
Brouillet S; Hoffmann P; Feige JJ; Alfaidy N
Trends Endocrinol Metab; 2012 Oct; 23(10):501-8. PubMed ID: 22709436
[TBL] [Abstract][Full Text] [Related]
37. The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism.
Abreu AP; Kaiser UB; Latronico AC
Neuroendocrinology; 2010; 91(4):283-90. PubMed ID: 20502053
[TBL] [Abstract][Full Text] [Related]
38. The immunohistochemical expression of endocrine gland-derived-VEGF (EG-VEGF) as a prognostic marker in ovarian cancer.
Bălu S; Pirtea L; Gaje P; Cîmpean AM; Raica M
Rom J Morphol Embryol; 2012; 53(3):479-83. PubMed ID: 22990536
[TBL] [Abstract][Full Text] [Related]
39. The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).
Goi T; Nakazawa T; Hirono Y; Yamaguchi A
Oncotarget; 2015 Oct; 6(30):28790-9. PubMed ID: 26318037
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
